Salud financiera de hoja de balance de AnteoTech

Salud financiera controles de criterios 6/6

AnteoTech tiene un patrimonio de los accionistas total de A$4.8M y una deuda total de A$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son A$7.4M y A$2.6M respectivamente.

Información clave

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$4.64m
Patrimonio	AU$4.75m
Total pasivo	AU$2.65m
Activos totales	AU$7.40m

Actualizaciones recientes sobre salud financiera

Recent updates

We're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn Rate

Mar 01

Will AnteoTech (ASX:ADO) Spend Its Cash Wisely?

May 05

Is AnteoTech (ASX:ADO) In A Good Position To Invest In Growth?

Dec 14

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

Aug 12

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

Apr 19

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

Oct 09

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

Apr 28

We're Not Very Worried About AnteoTech's (ASX:ADO) Cash Burn Rate

Jan 07

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$5.1M) de ADO superan a sus pasivos a corto plazo (A$1.8M).

Pasivo a largo plazo: Los activos a corto plazo de ADO (A$5.1M) superan a sus pasivos a largo plazo (A$891.6K).

Historial y análisis de deuda-patrimonio

Nivel de deuda: ADO está libre de deudas.

Reducción de la deuda: ADO no tenía deudas hace 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: ADO tiene suficiente cash runway para 8 meses según el flujo de caja libre último declarado, pero desde entonces ha obtenido capital adicional.

Pronóstico de cash runway: Se prevé que ADO disponga de suficiente cash runway para 7 meses según las estimaciones de flujo de caja libre, aunque ha obtenido desde entonces capital adicional.

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de AnteoTech

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

We're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn Rate

Will AnteoTech (ASX:ADO) Spend Its Cash Wisely?

Is AnteoTech (ASX:ADO) In A Good Position To Invest In Growth?

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

AnteoTech Limited SHS to Be Deleted from OTC Equity

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

Recent updates

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.

AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.

We're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

New minor risk - Financial data availability

Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer

AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023

New major risk - Share price stability

AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors

Will AnteoTech (ASX:ADO) Spend Its Cash Wisely?

Board Member exercised options to buy AU$70k worth of stock.

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023

Non-Executive Director recently sold AU$61k worth of stock

Is AnteoTech (ASX:ADO) In A Good Position To Invest In Growth?

High number of new and inexperienced directors

AnteoTech Ltd Announces Halt of European Rat Clinical Trial to Refocus Initiatives

AnteoTech Limited Appoint Executives

Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021)

AnteoTech Limited, Annual General Meeting, Nov 17, 2022

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

AnteoTech Limited Appoints David Radford as Managing Director, Effective from 4 October 2022

AnteoTech Limited SHS to Be Deleted from OTC Equity

Non-Executive Director recently sold AU$106k worth of stock

AnteoTech Ltd Announces Updated COVID-19 RAT Receives Regulatory Approval in Europe

Non-Executive Director recently sold AU$220k worth of stock

High number of new and inexperienced directors

AnteoTech Limited Announces Executive Changes

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

Non-Executive Director recently sold AU$108k worth of stock

Company Secretary Duncan Cornish has left the company

High number of new and inexperienced directors

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

High number of new and inexperienced directors

Independent Non-Executive Director recently bought AU$59k worth of stock

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020)

Chief Financial Officer Gail Jukes has left the company

Non-Executive Director recently sold AU$112k worth of stock

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 12.000001 million.

AnteoTech Limited announced that it expects to receive AUD 12.000001 million in funding

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

Independent Non-Executive Director has left the company

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

New 90-day high: AU$0.21

AnteoTech Customer Ellume Secures Us Contract

We're Not Very Worried About AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Progresses COVID-19 Test Toward Market Launch

AnteoTech Ltd Freeze Design of COVID-19 Antigen Rapid Test After Showing Saliva Proxy Sample Use Case Effectiveness

Independent Non-Executive Director exercised options to buy AU$208k worth of stock.

Full year earnings released - AU$0.002 loss per share

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera